Clindamycin combination products for acne bring together a topical antibiotic with other active ingredients in one prescription formulation. U.S. examples include clindamycin plus benzoyl peroxide gels, clindamycin plus tretinoin gels, and the three-ingredient CABTREO product. Begin with the clindamycin acne treatment context if you need the clinical reason combinations are considered.
A fixed-combination product is not the same as a tube of plain clindamycin gel. Benzoyl peroxide, tretinoin and adapalene serve different roles, have different irritation profiles and change how the product is prescribed. Even two preparations that both contain clindamycin may have different percentage strengths, labeled age ranges, application instructions and containers.
This is a routing hub: compare formulation families here, then use the focused clindamycin–benzoyl peroxide guide, clindamycin–tretinoin guide or triple-combination guide for specific ingredient questions.
Two-ingredient clindamycin/benzoyl peroxide gel pairs an antibiotic with an oxidizing acne ingredient. Clindamycin/tretinoin gel pairs the antibiotic with a topical retinoid. CABTREO contains clindamycin phosphate, adapalene and benzoyl peroxide in a single three-ingredient prescription gel.
These are distinct products, not alternate names for the same formulation. The table summarizes what a pharmacist or prescriber must check before a brand or package is selected; it does not rank efficacy or authorize automatic substitution.
| Product family | Ingredients | Example label | Main decision question |
|---|---|---|---|
| Antibiotic + benzoyl peroxide | Clindamycin phosphate + benzoyl peroxide | Acanya 1.2% / 2.5% | Which concentration and fixed product were prescribed? |
| Antibiotic + benzoyl peroxide | Clindamycin phosphate + benzoyl peroxide | Onexton 1.2% / 3.75% | Is this exact two-ingredient gel ordered? |
| Antibiotic + retinoid | Clindamycin phosphate + tretinoin | Ziana 1.2% / 0.025% | Were retinoid precautions reviewed? |
| Triple combination | Clindamycin phosphate + adapalene + benzoyl peroxide | CABTREO 1.2% / 0.15% / 3.1% | Are all three actives on the prescription? |
| Plain antibiotic | Clindamycin topical only | Gel, lotion or solution | Do not substitute for the combination without approval |
American Academy of Dermatology acne guidance recommends using benzoyl peroxide with topical antibiotics to help limit antibiotic resistance. That recommendation is relevant when a clinician considers a clindamycin-containing plan, but it does not mean every patient must use the same fixed-combination tube.
A prescription can involve a fixed gel or, in some cases, separate products at a clinician’s direction. The benzoyl peroxide buying guide covers the stand-alone ingredient; it is not a shortcut to obtaining a prescription combination without medical review.
U.S. product labeling includes combinations with different benzoyl peroxide concentrations; for example, Acanya is labeled 1.2% clindamycin phosphate/2.5% benzoyl peroxide, while Onexton is labeled 1.2%/3.75%. Other product families use different stated strengths and package directions.
Do not compare two cartons by the benzoyl peroxide number alone. Confirm both actives, the basis of the clindamycin strength and the intended formulation. Brand-specific information can be reviewed on Acanya and Onexton pages.
Clindamycin/tretinoin preparations use a retinoid rather than benzoyl peroxide as the second ingredient. Ziana labeling identifies clindamycin phosphate 1.2% with tretinoin 0.025%. Tretinoin can increase sensitivity to irritation and makes product-specific skin care and sun-exposure precautions important.
The combined prescription should not be treated like plain topical antibiotic lotion or like a freely interchangeable stand-alone tretinoin product. Learn about the individual retinoid through topical tretinoin access while keeping the fixed-combination instructions separate.
CABTREO is a distinct prescription triple combination containing clindamycin phosphate 1.2%, adapalene 0.15% and benzoyl peroxide 3.1%, indicated for acne vulgaris in patients 12 years and older. It is a single labeled gel supplied in pump packaging, not a kit of individually purchased treatments or a synonym for another clindamycin-containing acne brand.
Patients should not try to imitate its proportions by mixing independent OTC and prescription products. Our CABTREO product page focuses on the named brand and labeling; the formulation overview focuses on why the triple formula is distinct.
Plain clindamycin gel, solution or lotion contains the topical antibiotic without the additional benzoyl peroxide or retinoid in a fixed product. Combination gels have extra actives that can affect irritation, selection, price and instructions. A pharmacy must match all ingredients listed on the prescription.
The topical clindamycin forms guide is the correct hub for single-ingredient products. The patient should not request a combination replacement simply because a plain clindamycin SKU is unavailable.
Dryness, burning, peeling and redness can occur with topical acne agents and may be more noticeable when several irritating products are used together. Retinoid-containing labels have additional sunlight and skin-irritation precautions; benzoyl peroxide can bleach fabrics and hair.
Ask the treating clinician to review the complete skin-care routine, including scrubs, exfoliating acids and other acne products. A package offering more actives is not automatically more tolerable or suitable for every skin type.
Topical use does not eliminate the systemic safety considerations of clindamycin. The labeled CABTREO triple gel and many clindamycin/benzoyl peroxide combination gels formally contraindicate use after regional enteritis, ulcerative colitis or antibiotic-associated colitis, and in patients with particular histories of hypersensitivity. Other fixed combinations may have their own wording, so no universal contraindication list should replace the exact product label.
Significant diarrhea, bloody diarrhea or other concerning reactions need clinical evaluation even if a product was applied only to the skin. Discuss prior C. difficile infection and relevant bowel disease before the prescription is written. The C. difficile risk page covers this serious antibiotic-related warning, while the individual brand label controls the final product restrictions.
A valid U.S. prescription should specify the desired fixed combination, formulation and directions. Pharmacy software may offer brand and generic product entries with closely related names; the pharmacist needs to confirm that the listed ingredients and strengths match the authorized prescription.
For legitimate dispensing steps after the product is chosen, see buying prescription clindamycin plus benzoyl peroxide. This hub does not duplicate that checkout workflow.
Insurance, brand status, the number of active ingredients, package size, dispensing pharmacy and formulary restrictions all affect out-of-pocket cost. A marketed package or coupon claim does not prove coverage for a particular patient or make two different formulations therapeutically equivalent.
Ask for a current quote for the exact prescription and compare benefit rules before discussing changes. The topical clindamycin cost overview describes broader cost factors in an evergreen format.
Useful questions include which acne features the clinician is targeting, whether a retinoid or benzoyl peroxide is being added, how the plan avoids antibiotic monotherapy and what irritation precautions apply. The answer depends on the person’s skin, prior treatment and tolerability.
Do not interpret this list as a do-it-yourself regimen or a recommendation to layer independent products. The goal is to understand why one prescribed fixed combination differs from another and how to recognize it on the pharmacy label.
Verify the full product name, each active ingredient, exact stated percentages, U.S. prescription, package form and patient directions. If a pharmacist proposes a different combination, ask what changed and whether the prescriber authorized the substitution.
For a brand-level review, continue to the appropriate product page; for pharmacy availability questions, use the availability verification guide. No live stock, rankings or particular seller are asserted here.
Prescription topical formulations pairing clindamycin with benzoyl peroxide or a retinoid, including a three-ingredient formulation containing adapalene and benzoyl peroxide.
No. The partner ingredient, concentration, label directions and brand differ.
No. CABTREO also contains the retinoid adapalene and has specific labeled percentages.
Dermatology guidelines support benzoyl peroxide use alongside topical antibiotics to help reduce antibiotic resistance.
No. The fixed combination discussed here is prescription-only in the United States.
No. Do not attempt to recreate a fixed-dose formulation by mixing separate products; clinicians should guide regimen selection.
No. These are skin-directed acne products and must not be used intravaginally.
A pharmacist must verify the prescription and appropriate substitution. Matching one number is insufficient.
Yes. Topical clindamycin can be systemically absorbed. Several fixed acne-combination labels formally contraindicate use in people with certain inflammatory bowel or antibiotic-associated colitis histories and warn about significant diarrhea.